Document Detail


Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
MedLine Citation:
PMID:  7810636     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of brain mineralocorticoid receptor (MR) sites in the pathogenesis of mineralocorticoid hypertension was studied after an intracerebroventricular injection of the MR antagonist RU-28318. Male Wistar rats received subcutaneously implanted deoxycorticosterone acetate (DOCA) pellets and were maintained on 0.9% saline as drinking solution. Under these conditions hypertension developed in approximately 5 wk as assessed in conscious rats by means of the tail-cuff technique. During the development of this hypertension (after 3 wk of DOCA-salt treatment) a single intracerebroventricular injection of the specific MR antagonist RU-28318 reduced systolic blood pressure (SBP) as measured with the tail-cuff method. A decrease in SBP was observed 2-24 h after this intracerebroventricular injection, with the lowest SBP values occurring at 8 h. In these animals (3 wk after DOCA implantation) continuous direct blood pressure recording via chronic cannulation revealed, on the day of the intracerebroventricular injection of RU-28318, a slight increase in arterial pressure during the light phase, followed by a decrease during the dark phase. In the established hypertensive rats (5 wk after DOCA RU-28318 on the arterial pressure or heart rate was detectable. It is concluded that central MR blockade during the development of the DOCA-salt hypertension reduces blood pressure within 24 h assessed with 1) the indirect method at certain time points after exposure to warming and stress and 2) the direct method during the dark phase of the diurnal cycle.
Authors:
D T Van den Berg; E R de Kloet; W de Jong
Related Documents :
18055516 - At1 receptor antagonism attenuates target organ effects of salt excess in shrs without ...
1760376 - Chronic effects of high salt intake and conflict stress on blood pressure in primates. ...
11057426 - The lack of a modulating effect of non-genetic factors (age, gonads and maternal enviro...
17641406 - The role of endothelin-1 in human hypertension.
1513146 - Mechanical assistance of the left ventricle: acute effect on cardiac performance and co...
7095396 - Effects of diltiazem on renovascular-hypertensive and on normotensive rats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of physiology     Volume:  267     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1995-01-31     Completed Date:  1995-01-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  E927-33     Citation Subset:  IM    
Affiliation:
Leiden/Amsterdam Center for Drug Research, Sylvius Laboratories, Leiden University, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone Antagonists / pharmacology*
Animals
Blood Pressure / drug effects*
Brain / drug effects*
Desoxycorticosterone
Heart Rate / drug effects
Hypertension / physiopathology*
Male
Rats
Rats, Wistar
Receptors, Mineralocorticoid / antagonists & inhibitors*,  physiology
Sodium Chloride
Spironolactone / analogs & derivatives*,  pharmacology
Chemical
Reg. No./Substance:
0/Aldosterone Antagonists; 0/Receptors, Mineralocorticoid; 52-01-7/Spironolactone; 64-85-7/Desoxycorticosterone; 7647-14-5/Sodium Chloride; 76676-34-1/RU 28318

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily wa...
Next Document:  Fat metabolism during low-intensity exercise in endurance-trained and untrained men.